RU2006144122A - Идентификация и характеризация субпопуляции глиобластом, чувствительных к лечению иматинибом - Google Patents

Идентификация и характеризация субпопуляции глиобластом, чувствительных к лечению иматинибом Download PDF

Info

Publication number
RU2006144122A
RU2006144122A RU2006144122/13A RU2006144122A RU2006144122A RU 2006144122 A RU2006144122 A RU 2006144122A RU 2006144122/13 A RU2006144122/13 A RU 2006144122/13A RU 2006144122 A RU2006144122 A RU 2006144122A RU 2006144122 A RU2006144122 A RU 2006144122A
Authority
RU
Russia
Prior art keywords
mammal
expression
phosphorylation
susceptible
cell proliferative
Prior art date
Application number
RU2006144122/13A
Other languages
English (en)
Russian (ru)
Inventor
Моника Нистер (Se)
Моника НИСТЕР
Даниель ХЭГЕРСТРАНД (SE)
Даниель ХЭГЕРСТРАНД
Геран ХЕССЕЛАГЕР (SE)
Геран ХЕССЕЛАГЕР
Арне ОСТМАН (SE)
Арне ОСТМАН
Original Assignee
Лудуиг Инститьют Фор Кэнсе Рисеч (Us)
Лудуиг Инститьют Фор Кэнсе Рисеч
Уппсала Юниверсити Хоспитал (Se)
Уппсала Юниверсити Хоспитал
Моника Нистер (Se)
Моника НИСТЕР
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0410883A external-priority patent/GB0410883D0/en
Priority claimed from GB0425257A external-priority patent/GB0425257D0/en
Application filed by Лудуиг Инститьют Фор Кэнсе Рисеч (Us), Лудуиг Инститьют Фор Кэнсе Рисеч, Уппсала Юниверсити Хоспитал (Se), Уппсала Юниверсити Хоспитал, Моника Нистер (Se), Моника НИСТЕР filed Critical Лудуиг Инститьют Фор Кэнсе Рисеч (Us)
Publication of RU2006144122A publication Critical patent/RU2006144122A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
RU2006144122/13A 2004-05-14 2005-05-13 Идентификация и характеризация субпопуляции глиобластом, чувствительных к лечению иматинибом RU2006144122A (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0410883.3 2004-05-14
GB0410883A GB0410883D0 (en) 2004-05-14 2004-05-14 Organic compounds
GB0425257.3 2004-11-16
GB0425257A GB0425257D0 (en) 2004-11-16 2004-11-16 Organic compounds
PCT/EP2005/005269 WO2005113801A2 (en) 2004-05-14 2005-05-13 Identification and characterization of a subset of glioblastomas sensitive to treatment with imatinib

Publications (1)

Publication Number Publication Date
RU2006144122A true RU2006144122A (ru) 2008-06-20

Family

ID=35295424

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006144122/13A RU2006144122A (ru) 2004-05-14 2005-05-13 Идентификация и характеризация субпопуляции глиобластом, чувствительных к лечению иматинибом

Country Status (9)

Country Link
US (1) US20080199855A1 (enExample)
EP (1) EP1756306A2 (enExample)
JP (1) JP2007536920A (enExample)
AU (1) AU2005245572B9 (enExample)
BR (1) BRPI0511088A (enExample)
CA (1) CA2564654A1 (enExample)
MX (1) MXPA06013079A (enExample)
RU (1) RU2006144122A (enExample)
WO (1) WO2005113801A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2132336A1 (en) * 2007-03-02 2009-12-16 Board of Regents, The University of Texas System Multigene assay to predict outcome in an individual with glioblastoma
BR112012004237A8 (pt) * 2009-08-25 2016-10-04 Berg Pharma Llc métodos para tratamento de um sarcoma usando um alterador epimetabólico (coenzima q10)
EA201691257A1 (ru) * 2011-06-02 2017-02-28 Олмак Дайэгностикс Лимитед Молекулярно-диагностический тест на рак
HK1214633A1 (zh) 2012-12-03 2016-07-29 Almac Diagnostics Limited 癌症的分子诊断测试
GB201409479D0 (en) 2014-05-28 2014-07-09 Almac Diagnostics Ltd Molecular diagnostic test for cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2829154B1 (fr) * 2001-09-05 2003-10-17 Assist Publ Hopitaux De Paris Nouveau procede de detection d'une mutation en phase de lecture dans une sequence codante et appareil pour sa mise en oeuvre
WO2003087404A1 (en) * 2002-04-17 2003-10-23 Novartis Ag Methods to predict patient responsiveness to tyrosine kinase inhibitors
JP4035600B2 (ja) * 2002-05-22 2008-01-23 国立大学法人 東京大学 イマチニブに対する感受性の判定方法

Also Published As

Publication number Publication date
AU2005245572B9 (en) 2009-01-29
CA2564654A1 (en) 2005-12-01
MXPA06013079A (es) 2007-10-08
US20080199855A1 (en) 2008-08-21
AU2005245572B2 (en) 2008-12-04
AU2005245572A1 (en) 2005-12-01
JP2007536920A (ja) 2007-12-20
EP1756306A2 (en) 2007-02-28
BRPI0511088A (pt) 2007-12-26
WO2005113801A2 (en) 2005-12-01
WO2005113801A3 (en) 2006-02-23

Similar Documents

Publication Publication Date Title
Fan et al. Diagnosing sepsis–The role of laboratory medicine
Khalifian et al. The use of luminex assays to measure cytokines
JP2022519897A (ja) 対象の妊娠関連状態を決定するための方法及びシステム
JP6198736B2 (ja) 疾患のシグネチャとしてのアイソタイププロファイルの検出
US20180265923A1 (en) Biomarkers for Heart Failure
CN102301234A (zh) 针对重度抑郁疾病的代谢综合症状及hpa轴生物标志物
WO2021160978A1 (en) Method for predicting the likelihood of ectopic pregnancy (ep), viable intrauterine pregnancy (viup), or non-viable intrauterine pregnancy (nviup).
Breithaupt et al. Identification of State Markers in Anorexia Nervosa: Replication and Extension of Inflammation-Associated Biomarkers Using Multiplex Profiling
RU2006144122A (ru) Идентификация и характеризация субпопуляции глиобластом, чувствительных к лечению иматинибом
RU2714752C2 (ru) Способ измерения изменения в иммунном репертуаре индивидуума
WO2005118403A3 (en) Methods for detecting gene expression in peripheral blood cells and uses thereof
EP3599286B1 (en) Biomarkers for diagnosis and/or prognosis of frailty
CN118979104A (zh) 脓毒症相关疾病早期诊断标志物及其用途
WO2008063521A2 (en) Gene-based clinical scoring system
JP2011523037A5 (enExample)
WO2023178343A2 (en) Biomarkers for the diagnosis of parkinson's disease
WO2018234549A1 (en) Bodytime - a new diagnostic tool to assess the internal clock
CN110459312A (zh) 类风湿性关节炎易感位点及其应用
US20110275085A1 (en) Method for detection of autoimmune diseases
WO2014036518A2 (en) Use of interleukin-27 as a diagnostic biomarker for bacterial infection in critically ill patients
WO2010136576A1 (en) In vitro diagnosis/prognosis method and kit for assessment of tolerance in liver transplantation
JP2007536920A5 (enExample)
RU2801174C1 (ru) Способ прогнозирования риска развития сахарного диабета 2 типа у лиц с ожирением и/или предиабетом
EP2818546B1 (en) Method for determining rheumatoid arthritis activity indicator, and biomarker used therein
WO2016021719A1 (ja) 気分障害マーカーおよびその用途、ならびに統合失調症マーカーおよびその用途

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20100119